How Long Does Untreated Depression Last? What the Research Actually Shows

Most people who are living with depression want to know one thing: when will this end?

The honest answer is that it depends, and the single biggest factor is whether you’re getting care. Research consistently shows that untreated depression lasts significantly longer than treated depression, recurs more often, and becomes progressively harder to break out of. This page covers what the clinical evidence actually says about how long depression lasts, why waiting is not a neutral choice, and what changes when treatment starts.

What This Page Covers

• Average duration of untreated depression by type
• Why depression episodes tend to recur and worsen over time
• How treatment changes the timeline
• When “waiting it out” carries real risk
• What long-term management looks like

How Long Does Untreated Depression Last?

The short answer: longer than most people expect, and with more consequences than they realize.

In clinical populations, untreated major depressive disorder (MDD) episodes last an average of 6–12 months. Community-based research puts the median closer to 3 months, but community samples capture milder presentations that clinical settings don’t. For people whose depression is severe enough to seek care, or who are struggling in silence without knowing why, the 6–12 month range is the more relevant benchmark.

About 20% of people with untreated depression still meet full diagnostic criteria after one year, and roughly 10% continue to have symptoms beyond two years. These aren’t edge cases. They represent a substantial portion of people who experience depression as an extended, chronic state rather than a discrete episode.

Duration by Depression Type

Depression is not one condition with one timeline. The type significantly shapes how long an episode lasts.

Major Depressive Disorder (MDD): A single MDD episode untreated typically lasts 6–12 months. The defining feature is that most people with MDD don’t have just one episode. Research shows that 50–85% of people who experience one major depressive episode will experience additional ones throughout their lifetime. Each subsequent episode tends to have a lower triggering threshold and, without treatment, may last longer.

Persistent Depressive Disorder (Dysthymia): By definition, symptoms must be present on most days for at least two years for a clinical diagnosis. Many people with persistent depressive disorder (PDD) don’t recognize that what they’re experiencing is a medical condition. The mood has become their baseline. PDD’s symptoms are generally less severe than MDD but can persist for many years without treatment, and many people with PDD have also experienced major depressive episodes layered on top, a presentation called “double depression.”

Seasonal Affective Disorder (SAD): Episodes typically align with reduced daylight and last approximately 4–5 months, resolving in spring. Without treatment, the pattern tends to repeat annually. Light therapy and antidepressant medication are effective interventions.

Postpartum Depression: Can begin during pregnancy or in the year following childbirth. Without treatment, postpartum depression does not always resolve quickly. Research suggests that untreated cases can persist well beyond the newborn period and become long-term issues.

Bipolar Depression: Depressive episodes in bipolar disorder typically last 8–12 weeks, though the risk of recurrence is high without mood stabilization. Treating bipolar depression requires a different approach than unipolar MDD and should always involve a prescriber experienced with the distinction.

Why Untreated Depression Gets Worse Over Time

One of the most important things the research has clarified over the past two decades is that depression is not passive. An untreated episode doesn’t simply occupy a fixed period and then leave. It actively changes the conditions that determine whether future episodes occur.

The concept of “kindling” in mood disorders describes how early depressive episodes appear to sensitize the brain to subsequent ones. With each episode, the threshold for what triggers a recurrence decreases. Early research and subsequent population studies suggest that the number of prior depressive episodes is one of the strongest predictors of future episodes, more so than family history or current stressors.

Beyond neurobiology, untreated depression compounds. It strains relationships, impairs occupational functioning, increases risk of substance use, and raises the probability of a co-occurring anxiety disorder. Each of these factors, in turn, extends the episode and makes the next one more likely.

The Gap Between Experiencing Depression and Getting Care

Research suggests that a substantial proportion of people experiencing depression avoid seeking professional help. The reasons are well-documented: stigma, access barriers, cost, the belief that it will pass, and for many people, the depression itself making it difficult to act.

This is one of the core problems that continuous, low-friction care models are built to address. When access requires a months-long wait for an initial appointment, a person in a depressive episode may not make it to that appointment at all. When care requires a name, an email, and a credit card before any clinical conversation happens, many people who most need help don’t get started.

The friction isn’t just inconvenient. It translates directly into weeks and months of an untreated episode extending, the risk of recurrence increasing, and a return to baseline becoming harder to reach.

How Treatment Changes the Timeline

Treatment dramatically changes what depression looks like over time, not just for the current episode but for the trajectory of the condition.

Clinical trials consistently show that people who receive evidence-based treatment see initial symptom improvement within 4–6 weeks, with substantial symptom reduction occurring by weeks 8–12. That’s compared to the 6–12 month average for untreated episodes. The difference is not marginal.

For medication specifically:

• Weeks 1–2: The medication begins working at the neurochemical level. Symptoms often don’t improve noticeably yet. Side effects, if they occur, are typically most prominent in this window and tend to resolve.
• Weeks 4–6: Most people begin to notice initial changes. Sleep often improves before mood does.
• Weeks 8–12: For people who respond, substantial symptom reduction is typical by this point. If a medication hasn’t produced meaningful improvement at adequate dose by week 8, a prescriber may assess whether to adjust dose or consider a different medication.

Research shows that approximately 80–90% of people with clinical depression who seek treatment eventually see improvement. That number climbs further with continuous monitoring and adjustment. The version of care that produces the best outcomes is not a single prescription but an ongoing clinical relationship where the prescriber knows what’s actually happening between visits.

The Role of Adherence

Among adults who begin antidepressant treatment, 42% discontinue within the first 30 days, and 72% discontinue within the first 90 days. The reasons vary: side effects that felt unmanageable without support, early improvement that felt like recovery, lack of follow-up, or simply forgetting.

Discontinuing antidepressants before the treatment course is complete significantly raises the risk of relapse. Clinical guidelines recommend continuing medication for at least 6–12 months after remission for a first episode, and longer for people with a history of multiple episodes. Stopping abruptly, rather than tapering under clinical supervision, can also cause discontinuation symptoms.

Adherence is not a personal failing. It’s a systems problem. People drop off treatment when no one is tracking whether the medication is helping, when side effects are addressed too slowly, and when the next clinical contact is three months away.

What Long-Term Management Looks Like

Depression for many people is not a single episode that resolves and stays resolved. It’s a condition that requires attention over time.

This doesn’t mean everyone with depression needs medication indefinitely. Many people complete a course of treatment and remain well without ongoing pharmacotherapy. But it does mean that understanding your personal pattern, recognizing early warning signs, and having a clinical relationship you can return to quickly if something shifts matters enormously.

The things that predict better long-term outcomes are not complicated: consistent engagement with treatment, monitoring of sleep and mood patterns, a prescriber who can see the trajectory rather than reconstructing it from memory, and access to adjustment without waiting months.

“One of the most common patterns I see is someone who felt better, stopped their medication, and then found themselves back at square one, or worse, six months later,” says Wendy Delgado, P.A., of the SiggyMD clinical team. “The goal isn’t just to get out of the episode. It’s to understand what keeps someone stable and to have a plan that accounts for that. That requires continuity, not just a prescription.”

About SiggyMD

If you’re wondering how long your depression has gone without real attention, that’s a question worth sitting with. A 6-month or 12-month wait to feel better is not something you have to accept as the default.

SiggyMD provides clinician-supervised care for depression and anxiety, with daily check-ins that build a longitudinal record of what’s actually happening between visits. Every treatment plan is reviewed and approved by a licensed prescriber. The intake is free, anonymous, and requires no name, email, or account to begin.

For a related guide on taking action on depression, see our post on how to deal with depression.

Start your anonymous intake with SiggyMD. A real clinician reviews everything.

What Members Are Saying

LM

L.M., 31

Major Depressive Disorder

“I’d been in what I described as a ‘low period’ for about eight months before I actually did something about it. I didn’t realize how much I’d normalized it. Looking back, the fact that it was still going on at eight months without getting worse was actually luck. Starting treatment felt like stepping off a conveyor belt I didn’t know I was on.”

A.R., 28

Recurrent Depression

“I had one episode in my mid-20s that I waited out. It eventually lifted after maybe nine months. I thought that meant I could do it again. The second time was worse and lasted longer. When I finally got into treatment, my prescriber explained the kindling concept to me and it made a lot of sense. I wish someone had explained that the first time.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

If you are in crisis or experiencing thoughts of self-harm, call or text 988. If you are in immediate danger, call 911.

Sources

1. National Institute of Mental Health. Major Depression. NIMH Statistics. Reviewed 2023.

2. National Institute of Mental Health. Depression. NIMH. Reviewed 2023.

3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). APA Publishing, 2022.

4. Trivedi MH, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry. 2006;163(1):28-40.

5. Whiteford HA, et al. Global burden of disease attributable to mental and substance use disorders. Lancet. 2013;382(9904):1575-1586.

6. Rush AJ. STAR*D: What have we learned? American Journal of Psychiatry. 2007;164(2):201-204.

7. Perry R, et al. Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for Major Depressive Disorder: A Systematic Review of Clinical Trials. Primary Care Companion to the Journal of Clinical Psychiatry. 2009.

8. Greenberg PE, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Journal of Clinical Psychiatry. 2021;82(6).

9. Kessler RC, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.

10. National Institute of Mental Health. Postpartum Depression Facts. NIMH. Reviewed 2023.